Aggressive policies that target the use and promotion of off-label use are needed to prevent the use of drugs for non-approved indications with little benefit or with harmful outcomes. It should be ...

Kids ages 5 to 11 can now be vaccinated against COVID-19 following the Food and Drug Administration’s emergency use authorization of the Pfizer Bio-NTech vaccine for this age group and the Centers for ...

The majority of patients prescribed antipsychotic medications in state Medicaid programs are taking these agents for off-label indications. Continuously enrolled patients with at least 1 prescription ...

Doctors often prescribe antidepressants to tackle conditions like migraine headaches for which they aren’t technically approved. Now, researchers say such “off-label” usage mostly occurs without clear ...

In a recent national survey, a substantial minority of physicians erroneously believed that certain off-label uses of prescription drugs were approved by the Food and Drug Administration. This ...

The Food and Drug Administration (FDA) authorizes the marketing of drugs only for uses that the manufacturer has demonstrated to be safe and effective. However, the FDA does not regulate medical ...

Dabigatran has been readily integrated into clinical practice in the United States, primarily for treatment of atrial fibrillation (A-fib) but increasingly for off-label indications as well, according ...

The Food and Drug Administration has relaxed label requirements for taking the abortion-inducing mediation Mifeprex (mifepristone), a move that may make it easier to prescribe the drug in states that ...

There’s a new name on the lips of everyone looking to shed their last five, 10, or even 25 pounds. That name is semaglutide. Then, on Monday, New York published a feature about how trendy Ozempic and ...

The Food and Drug Administration (FDA) has approved new labeling for Naftin (naftifine HCl cream 2%; Merz Pharmaceuticals) adding additional information regarding use in the pediatric population. The ...